Related references
Note: Only part of the references are listed.Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice
Tien-Ching Chang et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
Alaeddin Khalil et al.
HAEMATOLOGICA (2022)
Maintaining Safety with SARS-CoV-2 Vaccines
Mariana C. Castells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Pfizer's vaccine raises allergy concerns
Jop de Vrieze
SCIENCE (2021)
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity
Kai-Wen Ho et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice
Meilyn Sylvestre et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures
David Sehnal et al.
NUCLEIC ACIDS RESEARCH (2021)
Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection
Akira Nishio et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
Zhao-Hua Zhou et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis
Xiaoping Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease
Aleksejs Sazonovs et al.
GASTROENTEROLOGY (2020)
Both IgM and IgG Antibodies against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice
Tien-Ching Chang et al.
PHARMACEUTICS (2020)
Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex
Even Chen et al.
ACS NANO (2020)
Bispecific antibody (HER2 x mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes
I-Ju Chen et al.
ACTA BIOMATERIALIA (2020)
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
James E. Frampton
DRUGS (2020)
Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice
Nehal E. Elsadek et al.
MOLECULAR PHARMACEUTICS (2020)
Effects of PEG anchors in PEGylated siRNA lipoplexes onin vitrogene-silencing effects and siRNA biodistribution in mice
Yoshiyuki Hattori et al.
MOLECULAR MEDICINE REPORTS (2020)
Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers
Justin T. Huckaby et al.
COMMUNICATIONS CHEMISTRY (2020)
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS
Till F. M. Andlauer et al.
BMC MEDICINE (2020)
Structural basis of polyethylene glycol recognition by antibody
Cheng-Chung Lee et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
B Cell Responses: Cell Interaction Dynamics and Decisions
Jason G. Cyster et al.
CELL (2019)
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
Michael Steurer et al.
HAEMATOLOGICA (2019)
The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses
S. Moein Moghimi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions
Gergely Tibor Kozma et al.
ACS NANO (2019)
Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs
Yaelle Bavli et al.
JOURNAL OF CONTROLLED RELEASE (2019)
PEGylated liposomes: immunological responses
Marwa Mohamed et al.
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)
Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008
Sofie G. Hojfeld et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc et al.
NATURE NANOTECHNOLOGY (2019)
Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized
Cosby A. Stone et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer
Yi-An Cheng et al.
BIOMATERIALS SCIENCE (2019)
Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia
Emily K. Browne et al.
JOURNAL OF PEDIATRIC ONCOLOGY NURSING (2018)
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group
Rachel E. Rau et al.
PEDIATRIC BLOOD & CANCER (2018)
Physician Awareness of Immune Responses to Polyethylene Glycol-Drug Conjugates
Morgan D. McSweeney et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes
Taro Shimizu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse
M. D. McSweeney et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
Barry W. Neun et al.
MOLECULES (2018)
Translational gaps in animal models of human infusion reactions to nanomedicines
S. Moein Moghimi et al.
NANOMEDICINE (2018)
ACCELERATED CLEARANCE OF ULTRASOUND CONTRAST AGENTS CONTAINING POLYETHYLENE GLYCOL IS ASSOCIATED WITH THE GENERATION OF ANTI- POLYETHYLENE GLYCOL ANTIBODIES
Samantha M. Fix et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2018)
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
Yuan-Chin Hsieh et al.
THERANOSTICS (2018)
Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo
Philippe Grenier et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Alnylam launches era of RNAi drugs
Ken Garber
NATURE BIOTECHNOLOGY (2018)
Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials
Soumi Gupta et al.
EBIOMEDICINE (2018)
Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance
Xiaohui Wei et al.
ACS OMEGA (2018)
Platelets expressing IgG receptor Fc gamma RIIA/CD32A determine the severity of experimental anaphylaxis
Heloise Beutier et al.
SCIENCE IMMUNOLOGY (2018)
C-C motif-ligand 2 inhibition with emapticap pegol ( NOX-E36) in type 2 diabetic patients with albuminuria
Jan Menne et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review
Haroon Hasan et al.
PEDIATRIC BLOOD & CANCER (2017)
The pathophysiology of anaphylaxis
Laurent L. Reber et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
A Hard(y) Look at B-1 Cell Development and Function
Nicole Baumgarth
JOURNAL OF IMMUNOLOGY (2017)
FDA-Approved Oligonucleotide Therapies in 2017
Cy A. Stein et al.
MOLECULAR THERAPY (2017)
A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol
Chia-Jung Chang et al.
NATURE COMMUNICATIONS (2017)
Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy
Yu-Cheng Su et al.
NATURE COMMUNICATIONS (2017)
Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
Xi Zhu et al.
THERANOSTICS (2017)
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone
Justin McCallen et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone
Justin McCallen et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Engineering Chimeric Receptors To Investigate the Size- and Rigidity-Dependent Interaction of PEGylated Nanoparticles with Cells
Wei-Chiao Huang et al.
ACS NANO (2016)
Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus
Christine E. Henry et al.
ACTA BIOMATERIALIA (2016)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
Qi Yang et al.
ANALYTICAL CHEMISTRY (2016)
Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules
Wen-Wei Lin et al.
ANALYTICAL CHEMISTRY (2016)
Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals
Bing-Mae Chen et al.
ANALYTICAL CHEMISTRY (2016)
Follicular Helper T Cells
Carola G. Vinuesa et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers
Qian Qin et al.
BIOMATERIALS (2016)
Immediate-type hypersensitivity to polyethylene glycols: a review
E. Wenande et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promise
Terhi Hermanson et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
Thomas J. Povsic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
Nancy J. Ganson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance
Kouichi Shiraishi et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A. Michael Lincoff et al.
LANCET (2016)
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
F. Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Christian Lubich et al.
PHARMACEUTICAL RESEARCH (2016)
Reloadable multidrug capturing delivery system for targeted ischemic disease treatment
Jasmine P. J. Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
2′Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors
Youngju Lee et al.
NUCLEIC ACID THERAPEUTICS (2016)
Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice
Yosuke Hashimoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
Taro Shimizu et al.
IMMUNOBIOLOGY (2015)
Selective Delivery of PEGylated Compounds to Tumor Cells by Anti-PEG Hybrid Antibodies
Hsin-Yi Tung et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
Yu Mima et al.
MOLECULAR PHARMACEUTICS (2015)
Toward reducing immunogenicity of enzyme replacement therapy: altering the specificity of human β-glucuronidase to compensate for α-iduronidase deficiency
Huai-Yao Chuang et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2015)
T cell help controls the speed of the cell cycle in germinal center B cells
Alexander D. Gitlin et al.
SCIENCE (2015)
Anti-PEG immunity: emergence, characteristics, and unaddressed questions
Qi Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN--1a and PEG-IFN-2a in naive patients
Heather Myler et al.
BIOANALYSIS (2015)
Anaphylactic Shock Caused by Ingestion of Polyethylene Glycol
Sun Hee Lee et al.
INTESTINAL RESEARCH (2015)
One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles
Chien-Han Kao et al.
BIOMATERIALS (2014)
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Johan J. F. Verhoef et al.
DRUG DISCOVERY TODAY (2014)
Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production
Y. Hashimoto et al.
GENE THERAPY (2014)
T Follicular Helper Cell Differentiation, Function, and Roles in Disease
Shane Crotty
IMMUNITY (2014)
Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin
Takuya Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses
Laszlo Dezsi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery
Amr S. Abu Lila et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial
Nicola Longo et al.
LANCET (2014)
Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals
Janos Szebeni
MOLECULAR IMMUNOLOGY (2014)
Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins
Mark G. P. Saifer et al.
MOLECULAR IMMUNOLOGY (2014)
Anaphylaxis and Hypotension after Administration of Peginesatide
Charles L. Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Removing T-cell epitopes with computational protein design
Chris King et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Christoph A. Diebolder et al.
SCIENCE (2014)
Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes: Review and Case Studies
Jennifer L. Rojko et al.
TOXICOLOGIC PATHOLOGY (2014)
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Michael S. Hershfield et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
Peter E. Lipsky et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Ex-Vivo/in-Vitro Anti-polyethylene Glycol (PEG) Immunoglobulin M Production from Murine Splenic B Cells Stimulated by PEGylated Liposome
Amr Selim Abu Lila et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
Fabien B. Vincent et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
Thomas J. Povsic et al.
EUROPEAN HEART JOURNAL (2013)
Endocytosis and Recycling of Immune Complexes by Follicular Dendritic Cells Enhances B Cell Antigen Binding and Activation
Balthasar A. Heesters et al.
IMMUNITY (2013)
Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon
Taro Shimizu et al.
IMMUNOBIOLOGY (2013)
Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy
Qiang Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan
ChunLei Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: Promise for clinical application
Ai Nagao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Hypersensitivity to Polyethylene Glycols
Sapna Shah et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon
Kouichi Shiraishi et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Innate B cell helpers reveal novel types of antibody responses
Carola G. Vinuesa et al.
NATURE IMMUNOLOGY (2013)
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
Samantha C. Gouw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Potential Capacity of Aptamers to Trigger Immune Activation in Human Blood
Meltem Avci-Adali et al.
PLOS ONE (2013)
PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
Martin Schlapschy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes
Andrea Cerutti et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Factor VIII inhibitors in hemophilia A: rationale and latest evidence
Char Witmer et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
Chemistry for peptide and protein PEGylation
M. J. Roberts et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Analytical Measurement of PEGylated Molecules
Tian-Lu Cheng et al.
BIOCONJUGATE CHEMISTRY (2012)
Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates
Merry R. Sherman et al.
BIOCONJUGATE CHEMISTRY (2012)
IgM memory B cells: a mouse/human paradox
Claude-Agnes Reynaud et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Fc-fusion proteins: new developments and future perspectives
Daniel M. Czajkowsky et al.
EMBO MOLECULAR MEDICINE (2012)
A frustrating problem: Accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats
Yongxue Zhao et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
The tick-over theory revisited: Is C3 a contact-activated protein?
Bo Nilsson et al.
IMMUNOBIOLOGY (2012)
Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: A possible mechanism and the potential for clinical application
Amr S. Abu Lila et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles
Hiroyuki Koide et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
Takuya Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: A porcine model
Janos Szebeni et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Accelerated blood clearance of pegylated liposomal topotecan: Influence of polyethylene glycol grafting density and animal species
Chunlei Li et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Super-hydrophilic zwitterionic poly(carboxybetaine) and amphiphilic non-ionic poly(ethylene glycol) for stealth nanoparticles
Zhiqiang Cao et al.
NANO TODAY (2012)
Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
Janos Szebeni et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
Irene Puga et al.
NATURE IMMUNOLOGY (2012)
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa et al.
NATURE MEDICINE (2012)
Biological Explanation of Clinically Observed Elevation of TFPI Plasma Levels After Treatment with TFPI-Antagonistic Aptamer BAX 499
Michael Dockal et al.
BLOOD (2012)
Effect of Increased Tissue Factor Pathway Inhibitor (TFPI) Levels On Factor Xa Inhibition and Global Hemostasis in the Presence of TFPI-Antagonistic Aptamer BAX 499
Michael Dockal et al.
BLOOD (2012)
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
Janos Szebeni et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Differences in Colloidal Structure of PEGylated Nanomaterials Dictate the Likelihood of Accelerated Blood Clearance
Lisa M. Kaminskas et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
A Rare Case of Anaphylaxis to Bowel Prep: A Case Report and Review of the Literature
Julia A. Savitz et al.
MILITARY MEDICINE (2011)
Nanoparticle PEGylation for imaging and therapy
Jesse V. Jokerst et al.
NANOMEDICINE (2011)
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
Jason R. Cantor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers
Yijuan Liu et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2011)
The double life of a B-1 cell: self-reactivity selects for protective effector functions
Nicole Baumgarth
NATURE REVIEWS IMMUNOLOGY (2011)
Sensitive Quantification of PEGylated Compounds by Second-Generation Anti-Poly(ethylene glycol) Monoclonal Antibodies
Yu-Cheng Su et al.
BIOCONJUGATE CHEMISTRY (2010)
High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations
Yu-Chang Wu et al.
BLOOD (2010)
Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter
Gabriel D. Victora et al.
CELL (2010)
Development of a Universal Anti-Polyethylene Glycol Reporter Gene for Noninvasive Imaging of PEGylated Probes
Kuo-Hsiang Chuang et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase
JingXia Cui et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88
Bing He et al.
NATURE IMMUNOLOGY (2010)
Poly(2-oxazoline)s: A Polymer Class with Numerous Potential Applications
Richard Hoogenboom
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9
Dong Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9
Daqing Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Volker Schellenberger et al.
NATURE BIOTECHNOLOGY (2009)
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Tsutomu Ishihara et al.
PHARMACEUTICAL RESEARCH (2009)
Mechanism and regulation of class switch recombination
Janet Stavnezer et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Methoxy polyethylene glycol-epoetin beta - A review of its use in the management of anaemia associated with chronic kidney disease
Monique P. Curran et al.
DRUGS (2008)
Overcoming the innate immune response to small interfering RNA
Adam Judge et al.
HUMAN GENE THERAPY (2008)
Particle size-dependent triggering of accelerated blood clearance phenomenon
Hiroyuki Koide et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process
I. Hamada et al.
MOLECULAR IMMUNOLOGY (2008)
Sheddable coatings for long-circulating nanoparticles
Birgit Romberg et al.
PHARMACEUTICAL RESEARCH (2008)
Size comparison between proteins PEGylated with branched and linear Poly(Ethylene glycol) molecules
Conan J. Fee
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner
Gijs Hardenberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Germinal-center organization and cellular dynamics
Christopher D. C. Allen et al.
IMMUNITY (2007)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout
John S. Sundy et al.
ARTHRITIS AND RHEUMATISM (2007)
Anaphylaxis: Lessons from mouse models
Fred D. Finkelman
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
FDA drug approval summary: Pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)
Patricia Anne Dinndorf et al.
ONCOLOGIST (2007)
Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy
DC Drummond et al.
CANCER RESEARCH (2006)
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
EWM Ng et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes
A Judge et al.
MOLECULAR THERAPY (2006)
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
NJ Ganson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products
C Fruijtier-Pölloth
TOXICOLOGY (2005)
Monoclonal antibody-based quantitation of poly(ethylene glycol-derivatized proteins, liposomes, and nanoparticles
TL Cheng et al.
BIOCONJUGATE CHEMISTRY (2005)
Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells
T Okada et al.
PLOS BIOLOGY (2005)
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
AD Judge et al.
NATURE BIOTECHNOLOGY (2005)
Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid
SC Semple et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
TACI and BAFF-R mediate isotype switching in B cells
E Castigli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs
G Garratty
TRANSFUSION MEDICINE REVIEWS (2004)
Immunogenicity of interferon beta: differences among products
A Bertolotto et al.
JOURNAL OF NEUROLOGY (2004)
Environmental and genetic factors influencing inhibitor development
J Oldenburg et al.
SEMINARS IN HEMATOLOGY (2004)
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions
A Chanan-Khan et al.
ANNALS OF ONCOLOGY (2003)
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
H Schellekens
CLINICAL THERAPEUTICS (2002)
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
MB Litinskiy et al.
NATURE IMMUNOLOGY (2002)
Bioequivalence and the immunogenicity of biopharmaceuticals
H Schellekens
NATURE REVIEWS DRUG DISCOVERY (2002)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys
DW Drolet et al.
PHARMACEUTICAL RESEARCH (2000)
Pegylated interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
P Glue et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Doxorubicin entrapped within liposome-associated antigens results in a selective inhibition of the antibody response to the linked antigen
C Oja et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2000)
Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors
I Bergman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Efficient clearance of poly(ethylene glycol)modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy
TL Cheng et al.
BIOCONJUGATE CHEMISTRY (2000)
B cells extract and present immobilized antigen: implications for affinity discrimination
FD Batista et al.
EMBO JOURNAL (2000)
Share Paper
